Table 1 Clinical characteristics and outcome of patients undergoing DCS
From: Study of damage control strategy for non-traumatic diseases: a single-center observational study
Characteristics | n = 26 |
|---|---|
Age (years) | 76 (47–88) |
Male, n (%) | 14 (53.8) |
Disease | |
Upper gastrointestinal perforation, n (%) | 1 (3.8) |
Lower digestive tract perforation, n (%) | 12 (46.2) |
Acute intestinal necrosis, n (%) | 9 (34.6) |
Strangulation ileus, n (%) | 3 (11.5) |
Others, n (%) | 1 (3.8) |
Dialysis history, n (%) | 2 (7.7) |
Diabetes history, n (%) | 4 (15.4) |
Taking steroid, n (%) | 3 (11.5) |
Preoperative SOFA score | 7.5 (2–16) |
Preoperative acute DIC scorea | 3 (1–8) |
Serum lactic acid level just before the end of surgery (mmol/L) | 5.5 (2.3–15.6) |
Septic shockb, n (%) | 26 (100) |
Fluid and blood transfusion volume during surgery (mL) | 3473 (667–7844) |
Use norepinephrine ≥ 0.2 μg/kg/min during surgery, n (%) | 20 (76.9) |
MAP at the start of surgery (mmHg) | 68 (33–107) |
MAP at the end of source control (mmHg) | 65 (51–101) |
28-day mortality, n (%) | 3 (11.5) |